Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Filings indexed 788 across all filing types
Latest filing 2024-04-24 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2023年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2023 年年度报告全文" which translates to "2023 Annual Report Full Text" for 康泰医学系统(秦皇岛)股份有限公司. It contains detailed sections including company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, important matters, shareholder information, bond information, and financial statements. The document includes signatures from the legal representative and accounting officers, and an audit report from Deloitte, indicating it is a comprehensive official annual report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-04-24 Chinese
2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as a 2023 annual report summary for 康泰医学系统(秦皇岛)股份有限公司, containing detailed financial data, business overview, shareholder information, and auditor's opinion. It includes comprehensive financial figures for the year 2023 and comparisons with previous years, as well as business and operational highlights. The length is over 5,000 characters and it is not merely an announcement or a certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-04-24 Chinese
《董事会薪酬与考核委员会工作细则》
Governance Information Classification · 95% confidence The document is titled as the "Board of Directors Remuneration and Assessment Committee Working Rules" of 康泰医学系统(秦皇岛)股份有限公司. It details the structure, responsibilities, procedures, and rules of the remuneration and assessment committee of the board. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, no earnings release, no merger or acquisition information, and no presentation or transcript. The document is a governance-related internal rules document about board committee operations and remuneration policies. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3204 characters, which is substantive and not a mere announcement. Therefore, the correct classification is CGR with high confidence.
2024-04-24 Chinese
关于2023年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2023 annual profit distribution plan of Kangtai Medical System (Qinhuangdao) Co., Ltd. It includes details about the profit distribution proposal, the board and supervisory committee approvals, and the need for shareholder meeting approval. The document does not contain full financial statements or comprehensive financial performance data but rather focuses on the dividend distribution plan and related approvals. It is a formal announcement of a dividend plan, not the dividend payment notice itself, but it fits best under the category of Notice of Dividend Amount (DIV) because it announces the dividend amount per share and the total dividend to be distributed, along with relevant procedural information. The document length is short (1751 characters), and it is not a full report or certification. Therefore, the appropriate classification is DIV with high confidence.
2024-04-24 Chinese
《董事会审计委员会工作细则》
Governance Information Classification · 95% confidence The document is titled "董事会审计委员会工作细则" which translates to "Board Audit Committee Working Rules". It details the structure, responsibilities, procedures, and governance of the company's audit committee. There are no financial statements, no fiscal period data, no earnings or financial results, and no announcement of voting or management changes. The document is a governance-related internal rules document for the audit committee, focusing on audit oversight and internal control processes. It does not contain audit reports or financial data itself, nor is it an announcement or a certification. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3120 characters, which is consistent with a detailed governance document rather than a brief announcement or a full annual report.
2024-04-24 Chinese
监事会关于公司内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's opinion on the company's internal control self-evaluation report for the year 2023. It references relevant laws and regulations and states that the supervisory board has reviewed the internal control self-evaluation report and provides their opinion. The document is short (474 characters) and serves as an announcement of the supervisory board's review and opinion rather than the full report itself. It does not contain detailed financial data or the full internal control report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2024-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.